NCT03245437CompletedPhase 4
Target Engagement and Response to Oxytocin
Effects of Oxytocin on Social Cognition Training: Relationship to Target Engagement
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
This study will measure whether the engagement of intranasal oxytocin with a brain target is related to effects on learning during a social cognition training program.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 59 (actual)
- First submitted
- 7 Aug 2017
- Start date
- 4 Jan 2018
- Primary completion date
- 31 Jul 2024
- Lead sponsor
- University of California, Los Angeles
- Diseases
- Schizophrenia
- NCT number
- NCT03245437
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 59
- From 4 Jan 2018 to the primary completion date, 31 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- positive pregnancy test history of head injury
Who the study is looking for
- Schizophrenia or schizoaffective disorder
- stable on an antipsychotic medication
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCLA Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.